ActiPatch Testimonial DDrew 5.0 star rating Back

New Post Public Reply Private Reply Replies (0) Message Board
Chanel5
459
ActiPatch Testimonial


DDrew
5.0 star rating
Back Pain No More
Review by Drew on 16 Apr 2019

"I'm strongly against taking pills, especially for pain. I've tried tens, that didn't work. A friend of mine told me to try Actipatch, said it worked great for their knee. I bought a 720 hour one. The price you couldn't beat. A lot cheaper than tens and no tingling feeling. I was told to wear the Actipatch for 7 days straight. By day 2 I could feelRead more about review stating Back Pain No More my back pain subsiding, that continued up until day 7. Wow, I was amazed on how great this product worked. Back pain basically gone. I can live a normal life again. Bought a few more boxes to have in stock. I still wear the Actipatch on my back during the day to keep the pain away. I'm so glad I was told about this product. Every chance I get I mention Actipatch to someone that is pain. Highly recommend!"

https://www.performancehealth.com/actipatch-a...ain-relief


BIEL TO THE RESCUE

Back Pain, Musculoskeletal Conditions etc

Key facts
Approximately 1.71 billion people have musculoskeletal conditions worldwide.
Musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries.
Musculoskeletal conditions significantly limit mobility and dexterity, leading to early retirement from work, lower levels of well-being and reduced ability to participate in society.
Because of population growth and ageing, the number of people living with musculoskeletal conditions and associated functional limitations, is rapidly increasing.
WHO is responding to the burden attributed to musculoskeletal conditions across a number of programmatic areas.
Scope
Musculoskeletal health refers to the performance of the locomotor system, comprising intact muscles, bones, joints and adjacent connective tissues. Musculoskeletal impairments comprise more than 150 different diseases/conditions that affect the system and are characterized by impairments in the muscles, bones, joints and adjacent connective tissues leading to temporary or lifelong limitations in functioning and participation. Musculoskeletal conditions are typically characterized by pain (often persistent) and limitations in mobility and dexterity, reducing people’s ability to work and participate in society. Pain experienced in musculoskeletal structures is the most common form of non-cancer pain.

Musculoskeletal conditions are relevant across the life-course – from childhood to older age. They range from those conditions that arise suddenly and are short-lived (such as fractures, sprains and strains, associated with pain and limitations in functioning) though to long-term conditions such as chronic primary low back pain and osteoarthritis.

Musculoskeletal conditions include conditions that affect:

joints, such as osteoarthritis, rheumatoid arthritis, psoriatic arthritis, gout, spondyloarthritis;
bones, such as osteoporosis, osteopenia and associated fragility fractures, traumatic fractures;
muscles, such as sarcopenia;
multiple body areas or systems, such as regional (e.g. back and neck pain) and widespread (e.g. fibromyalgia) pain conditions, inflammatory diseases such as connective tissue diseases and vasculitis that have musculoskeletal manifestations, for example systemic lupus erythematosus, or amputation as a result of disease or trauma.
Musculoskeletal conditions are also the highest contributor to the global need for rehabilitation. They are among the largest contributors to the need for rehabilitation services among children and account for approximately two-thirds of all adults in need of rehabilitation (1). Musculoskeletal conditions often co-exist with other noncommunicable diseases and increase the risk of developing other noncommunicable diseases, such as cardiovascular disease (2). People with musculoskeletal conditions are also at higher risk to develop mental health issues.

Magnitude
A recent analysis of Global Burden of Disease (GBD) 2019 data showed that approximately 1.71 billion people globally live with musculoskeletal conditions, including low back pain, neck pain, fractures, other injuries, osteoarthritis, amputation and rheumatoid arthritis (1). While the prevalence of musculoskeletal conditions varies by age and diagnosis, people of all ages everywhere around the world are affected. High-income countries are the most affected in terms of number of people – 441 million – followed by countries in the WHO Western Pacific Region with 427 million and South-East Asia Region with 369 million. Musculoskeletal conditions are also the biggest contributor to years lived with disability (YLDs) worldwide with approximately 149 million YLDs, accounting for 17% of all YLDs worldwide.

Low back pain is the main contributor to the overall burden of musculoskeletal conditions (570 million prevalent cases worldwide, responsible for 7.4% of global YLDs). Other contributors to the overall burden of musculoskeletal conditions include fractures with 440 million people globally (26 million YLDs), osteoarthritis (528 million people; 19 million YLDs), neck pain (222 million people; 22 million YLDs), amputations (180 million people; 5.5 million YLDs), rheumatoid arthritis (18 million people; 2.4 million YLDs), gout (54 million people; 1.7 million YLDs) other musculoskeletal conditions (453 million people; 38 million YLDs) [data from IHME Viz Hub and WHO Rehabilitation Needs Estimator].

While the prevalence of musculoskeletal conditions increases with age, younger people are also affected, often during their peak income-earning years. For example, childhood auto-immune inflammatory conditions such as juvenile arthritis affect children’s development, while low back pain is the main reason for a premature exit from the workforce. The societal impact of early retirement in terms of direct health-care costs and indirect costs (i.e., work absenteeism or productivity loss) is enormous. Projections show that the number of people with low back pain will increase in the future, and even more rapidly in low-income and middle-income countries (3).

Health estimates
The WHO Rehabilitation Need Estimator tool provides a unique opportunity to search for country, regional or global prevalence and YLD data on musculoskeletal conditions that can benefit from rehabilitation, based on GBD 2019 data. Similarly, the GBD Compare Tool also provides health estimates for musculoskeletal and other conditions. Variation in aggregated health estimates between the tools may be explained by differences in which specific musculoskeletal conditions and subgroups of those are included.

The WHO Ageing Data Portal brings together data on available global indicators relevant to monitoring the health and well-being of people aged 60 years and over. Through maps, charts and tables, the portal offers tailored options for visualization and analysis of the data. The portal provides prevalence data for low back pain in older people.

WHO response
Rehabilitation 2030

WHO launched the Rehabilitation 2030 initiative in 2017 to draw attention to the profound unmet need for rehabilitation worldwide, and to highlight the importance of strengthening rehabilitation in health systems. The initiative marks a new strategic approach for the global rehabilitation community by emphasizing that:

Rehabilitation is an essential health service and crucial for achieving universal health coverage.
Rehabilitation should be available for all the population, through all stages of the life course and along the continuum of care. This includes all people with musculoskeletal conditions.
Efforts to strengthen rehabilitation should be directed towards supporting health systems as a whole and integrating rehabilitation into all levels of health care.
The Rehabilitation 2030 initiative was launched to support countries to respond to existing rehabilitation needs, including of people with musculoskeletal conditions, as well as the forecasted increase arising from health and demographic trends. Rehabilitation is often not a political priority in countries and thus continues to be under-resourced. As a result, the rehabilitation needs of individuals continues to go unmet, leading to an exacerbation of their condition, lifelong consequences and inequities in health outcomes. Further information about the Rehabilitation 2030 initiative can be found here.
WHO is also developing a Package of Interventions for Rehabilitation including the following musculoskeletal conditions: low back pain, osteoarthritis, rheumatoid arthritis, sarcopenia, fractures in the extremities, and amputation. Each package will contain a list of essential interventions for rehabilitation and the resources required to deliver them safely and effectively. These interventions will be relevant for people at all stages of life, along the continuum of care, across all service delivery platforms, and across all world regions, with a specific focus on low- and middle-resource contexts.

The main target users of the Package of Interventions for Rehabilitation are Ministries of Health that can use this resource to plan and budget the integration of rehabilitation in their national health services. Other target users that may benefit from the Package of Interventions for Rehabilitation include researchers to identify rehabilitation research gaps; academics to develop curricula for the training of rehabilitation professionals; and service providers to plan and implement specific interventions in their rehabilitation programmes.

More about the Package of Interventions for Rehabilitation of musculoskeletal conditions can be found here.

Integrated Care for Older People (ICOPE)

Integrated care for older people (ICOPE) reflects a continuum of care that helps to reorient health and social services towards a more person-centred and coordinated model of care to optimize older people’s intrinsic capacity (physical and mental capacities) and functional ability. Locomotor (musculoskeletal) capacity is a key component of intrinsic capacity. Delivery of integrated care and primary health services responsive to older people is one of the action areas of UN Decade of Healthy Ageing (2021–2030). WHO has developed tools to support countries for implementation of the ICOPE approach that include:

guidelines on community-level interventions to manage declines in intrinsic capacity, including evidence to improve mobility;
ICOPE handbook: including specific pathways for mobility loss/impaired locomotor capacity; and
ICOPE implementation framework: guidance for systems and services.
WHO is currently developing evidence-based clinical guidelines for non-surgical management of chronic primary low back pain for adults. The recommendations to manage chronic primary low back pain will be integrated into ICOPE handbook.



1. Cieza, A., Causey, K., Kamenov, K., Hanson, S. W., Chatterji, S., & Vos, T. (2021). Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10267), 2006–2017.
2. Williams A, Kamper SJ, Wiggers JH, O'Brien KM, Lee H, Wolfenden L, Yoong SL, Robson E, McAuley JH, Hartvigsen J, Williams CM. Musculoskeletal conditions may increase the risk of chronic disease: a systematic review and meta-analysis of cohort studies. BMC Medicine 2018;16:167
3. Hartvigsen J, Hancock MJ, Kongsted A, et al. What low back pain is and why we need to pay attention. Lancet 2018; 391: 2356–67.


https://www.who.int/news-room/fact-sheets/det...conditions

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 72

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 105

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 337

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 508

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 83

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 727

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 587

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 171

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 341

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading

Top 5 Most Recently Viewed Articles

Introducing the Innovative Garage Door Opener for Homes

Updated Category News Views 201

Introducing the G3120HL Garage Door Opener Modern Design with Advanced Features – Beyond Basic. Built for More. MT. HOPE, Ohio — Genie®, known for its exceptional garage door innovations, has launched the G3120HL opener, fusing cutting-edge technology with an impressive industrial design. This opener enhances security, convenience, and durability, perfectly suited...

Continue Reading
Costamare Inc. Announces Latest Dividends for Investors

Updated Category News Views 68

Costamare Inc. (NYSE: CMRE) dropped a bombshell back in 2024, announcing hefty cash dividends that had traders buzzing. They laid out payments of US $0.476563 per share for the 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock, US $0.531250 for the 8.50% Series C, and US $0.546875 per share for the 8.75% Series D Preferred Stock. For investors eyeing a...

Continue Reading
TranscribeGlass Expands Orders for Vuzix Smart Glasses

Updated Category News Views 159

TranscribeGlass Orders More Vuzix Z100 Smart Glasses AI-driven speech-to-text technology is revolutionizing how we communicate. For those who are deaf or hard of hearing, this technology enhances accessibility and allows for real-time closed captions in various environments. Continued Demand for Transcription Solutions The demand for effective communication solutions is...

Continue Reading
Sandoz Q1 2025 Financial Performance Highlights and Insights

Updated Category News Views 544

Sandoz Reports Robust Q1 2025 Financials Sandoz has shared its financial updates for the first quarter of 2025, reflecting a strong performance that aligns well with the company's expectations. This report is particularly notable as it confirms the company's ongoing commitment to delivering high-quality generic and biosimilar medicines to global markets. Q1 Sales...

Continue Reading
Zero Candida Technologies Expands Investor Access and DTC Eligibility

Updated Category News Views 124

Exciting Developments from Zero Candida Technologies Zero Candida Technologies, Inc. (ZCT) is making significant strides in revolutionizing women's health with their innovative medical device approach. This FemTech company has recently announced that its common shares are now eligible for Depository Trust Company (DTC) electronic clearing and settlement services. This...

Continue Reading